Cover image of the article: Colonization with Clostridium difficile in Children with Cancer

Image Credit:Inn J Pediatr

Colonization with Clostridium difficile in Children with Cancer

Authors

Shahnaz Armin1,*, Shahin Shamsian2, Hojatollah Drakhshanfar3
*Corresponding Author: Email: arminsh_2000@yahoo.com

Innovative Journal of Pediatrics:Vol. 23, issue 4; 473-476
Published online:Mar 07, 2013
Article type:Brief Report
Received:Jul 29, 2012
Accepted:Feb 25, 2013
How to Cite:Armin S, Shamsian S, Drakhshanfar H. Colonization with Clostridium difficile in Children with Cancer. Inn J Pediatr. 2013;23(4):. doi:

Abstract

Objective: Clostridium difficile is a gram-positive, anaerobic, spore-forming bacillus. Usually it does not cause disease unless a patient who is colonized with toxin-producing strains has been treated with antibiotics, particularly those that change the anaerobic flora of the large intestine. Methods: We investigated in a prospective study intestinal colonization of C. difficile and its toxins in children with malignancy that used different antibiotics and cytotoxic drugs. Findings: One hundred fifty-two patients were included in this prospective study. Stool samples were obtained within the first 48 hours after admission and cultured for C. difficile; cytopathic effect of C. difficile was detected on HELA cells, also ELISA test was performed for detection of toxins A and B. 25% of patients had positive culture for C. difficile; 36/38 (92%) revealed positive cytopathic effect on HELA cells. No significant relation was found between age, gender, history of antibiotic consumption and C. difficile positive culture and cytopathic effect on HELA cells. The only relation was seen between cotrimoxazol usage and cytopathic effect on HELA cells (P=0.03). Conclusion: Although the rate of C. difficile colonization (25.6%) and toxigenic strains (23.7%) in admitted children in hematologic ward is high, the rate of ELISA positive test for toxin A+B was not correspond with culture and cytopatic effect on HELA cell. With respect to sensitivity and specificity of ELISA test, possibility for existence of toxin C with cytopathic effect is high in this type of patients.

 

Highlights

References

  • 1.
    References are available on the PDF.

Copyright

© 2013, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

15
May
2019
Spore Production of Toxigenic and Non-Toxigenic Clostridium difficile Isolates in Sub-MIC of Vancomycin, Clindamycin, and Ceftazidime

Spore Production of Toxigenic and Non-Toxigenic Clostridium difficile Isolates in Sub-MIC of Vancomycin, Clindamycin, and Ceftazidime

Ebrahim Rezazadeh Zarandi,
Shahla Mansouri,
Nouzar Nakhaee,
Farhad Sarafzadeh,
Mohammad Moradi

Rezazadeh Zarandi E, Mansouri S, Nakhaee N, Sarafzadeh F, Moradi M. Spore Production of Toxigenic and Non-Toxigenic Clostridium difficile Isolates in Sub-MIC of Vancomycin, Clindamycin, and Ceftazidime. Jundishapur J Microbiol. 2019;12(5):e57905. doi: https://doi.org/10.5812/jjm.57905

30
Jul
2007
Clostridium Difficile Colitis

Clostridium Difficile Colitis

Stephen B Calderwood

Calderwood SB. Clostridium Difficile Colitis. Arch Clin Infect Dis. 2007;2(3):e94191. doi:

2
Jul
2012
What’s up With Clostridium difficile Infection Now?

What’s up With Clostridium difficile Infection Now?

Masoud Mardani

Mardani M. What’s up With Clostridium difficile Infection Now?. Arch Clin Infect Dis. 2012;7(3):e93427. doi:

17
May
2020
Molecular Characterization and Diagnosis of Nosocomial Clostridium difficile Infection in Hospitalized Patients

Molecular Characterization and Diagnosis of Nosocomial Clostridium difficile Infection in Hospitalized Patients

Ali Majidpour,
Mina Boustanshenas,
Samira Rasouli Koohi,
Bita Bakhshi,
Mohammad Rahbar,
Parisa Kiani
,et al.

Majidpour A, Boustanshenas M, Rasouli Koohi S, Bakhshi B, Rahbar M, et al. Molecular Characterization and Diagnosis of Nosocomial Clostridium difficile Infection in Hospitalized Patients. Arch Clin Infect Dis. 2020;15(2):e97330. doi: https://doi.org/10.5812/archcid.97330

14
Mar
2023
Frequency of Clostridioides difficile Infection Among Hospitalized Patients in Kerman City, Iran

Frequency of Clostridioides difficile Infection Among Hospitalized Patients in Kerman City, Iran

Mohammad Saeed Shojaei,
Farokh Rokhbakhsh-Zamin,
Ebrahim Rezazadeh Zarandi,
Farhad Sarafzadeh,
Sayed Mohammad Reza Khoshroo

Shojaei MS, Rokhbakhsh-Zamin F, Rezazadeh Zarandi E, Sarafzadeh F, Khoshroo SMR. Frequency of Clostridioides difficile Infection Among Hospitalized Patients in Kerman City, Iran. Jundishapur J Microbiol. 2022;15(12):e132262. doi: https://doi.org/10.5812/jjm-132262

More by these authors

Shahnaz ArminPubMedScholar
Shahin ShamsianPubMedScholar
Hojatollah DrakhshanfarPubMedScholar
Share
Cited by
Metrics